Women's health (London, England)

Womens Health (Lond) · ISSN (e) 1745-5065 · 196 papers in corpus
review 2010
doi:10.2217/whe.10.39 ·PMID:20597619

Acupuncture is increasingly being used in reproductive medicine. This review summarizes the evidence of acupuncture in pain relief for oocyte retrieval, improving pregnancy outcomes of in vitro fertilization treatment, management of ovulati…

review 2010
doi:10.2217/whe.09.72 ·PMID:20001868

Dienogest (DNG), a progestin of 19-nortestosterone derivative, has good oral bioavailability and is highly selective for progesterone receptors. Owing to its antiovulatory, antiproliferative activities in endometrial cells, and its inhibito…

review 2010
doi:10.2217/whe.10.34 ·PMID:20597618

Technological advances in fiberoptics and endoscopy have resulted in the development of minimally invasive transcervical tubal catheterization procedures with the potential of improved diagnostic accuracy of tubal disease and transcervical …

meta-analysis 2010
doi:10.2217/whe.10.79 ·PMID:21175391

China was the first country in the world that approved mifepristone (RU-486) for abortion. A total of 6 years after the report published in the Western world indicated that mifepristone may also be effective in treating endometriosis, the f…

review 2009
doi:10.2217/whe.09.7 ·PMID:19392615

In the early days, all mucosal invasions of abdominal organs were considered to be one pathological condition of uncertain origin, termed adenomyoma. It was only in the 1920s that endometriosis and adenomyosis were clearly separated and it …

other 2009
doi:10.2217/17455057.5.1.39 ·PMID:19102639

In the Mayo Clinic Cohort Study of Oophorectomy and Aging, women who had both ovaries removed before reaching natural menopause experienced a long-term increased risk of parkinsonism, cognitive impairment or dementia, and depressive and anx…

review 2008
doi:10.2217/17455057.4.4.399 ·PMID:19072504

Although it is generally accepted that endometriosis is responsible for dysmenorrhea, as well as other symptoms such as infertility, the precise relationship between the severity of dysmenorrhea and various characteristics of disease, such …

review 2008
doi:10.2217/17455057.4.3.269 ·PMID:19072476

Progesterone-receptor modulators (PRMs) are progesterone-receptor ligands that can exert agonistic, antagonistic or mixed agonist-antagonist effects depending on the cellular context. The mechanisms of action of these compounds are still in…

review 2007
doi:10.2217/17455057.3.5.637 ·PMID:19804041

Endometriosis is a benign, estrogen-dependent disease and is now recognized as an enigmatic disease owing to its various clinical manifestations and locations. The lack of a reliable and specific method for the early detection of endometrio…

review 2007
doi:10.2217/17455057.3.5.629 ·PMID:19804040

Endometriosis is a gynecological disorder characterized by the growth of endometrial tissue outside the uterine cavity. Although the prevalence of endometriosis is well documented in women living in developed countries, studies on the preva…

other 2007
doi:10.2217/17455057.3.5.647 ·PMID:19804042

In women of reproductive age, health economic costs are estimated to be considerably higher for endometriosis than for conditions such as Crohn's disease, migraine and hypertension, and similar to the cost of diabetes. However, more awarene…

review 2007
doi:10.2217/17455057.3.2.207 ·PMID:19803853

Endometriosis-associated symptomatology can be safely and effectively treated with intrauterine-released progestin, which is associated with fewer adverse effects than other therapeutic options and may be used on a long-term basis. We have …

review 2007
doi:10.2217/17455057.3.2.195 ·PMID:19803852

Epilepsy affects 50 million people worldwide, including women afflicted with catamenial epilepsy. Catamenial epilepsy is a form of epilepsy in which seizures are clustered around specific points in the menstrual cycle, most frequently durin…

review 2007
doi:10.2217/17455057.3.5.617 ·PMID:19804039

Endometriosis is an estrogen-dependent disease and estrogen-related pathways are imbalanced in women with endometriosis. One of the key enzymes in estrogen synthesis is aromatase. Inhibiting this pathway at several points is a promising ide…

other 2007
doi:10.2217/17455057.3.5.615 ·PMID:19804038

10.2217/17455057.3.5.615 © part of Short biography Thomas D’Hooghe Clinical Head, Leuven University Fertility Center; Chair, European Society for Human Reproduction and Embryology Special Interest Group for Endometriosis; Editor-in-Chief, G…

review 2006
doi:10.2217/17455057.2.5.705 ·PMID:19803824

During the use of long-cycle regimens of monophasic oral contraceptives, the total number of bleeding and cycle-dependent complaints is considerably lower than during conventional treatment with oral contraceptives. Despite an initially hig…

review 2006
doi:10.2217/17455057.2.2.297 ·PMID:19803901

Current approved medical therapies for endometriosis rely on drugs that suppress ovarian steroids and induce a hypoestrogenic state, which determines the atrophy of the ectopic endometrium. Gonadotropin-releasing hormone analogs such as dan…

review 2006
doi:10.2217/17455057.2.4.617 ·PMID:19803969

Defined as the presence of functional endometrial tissue outside the uterine cavity, endometriosis is a chronic and recurrent disease that affects 7-10% of reproductive-age women, causing pain, infertility or both, resulting in serious life…

review 2006
doi:10.2217/17455057.2.2.191 ·PMID:19803889

Depot medroxyprogesterone acetate (DMPA; Depo-Provera) is a highly effective and convenient contraceptive method that has been used worldwide for many decades. Recently, a new lower dose of DMPA, administered as a subcutaneous injection, ha…

other 2005
doi:10.2217/17455057.1.3.447 ·PMID:19803886

Endometriosis is a disease that affects approximately 10% of all reproductive-aged women and the prevalence rises to 20-50% in infertile women. There is growing evidence that medicinal Chinese herbs with pain-alleviating and anti-inflammato…

other 2005
doi:10.2217/17455057.2.1.53 ·PMID:19803926

Lone Hummelshoj1†, Andrew Prentice2 & Patrick Groothuis3 †Author for correspondence 1Endometriosis.ORG, 89 Southgate Road, London, N1 3JS, UK. Tel.: +44 (0)7710 065 164; Fax: +44 (0)20 7354 4708; E-mail: [email protected] 2University D…